Christopher Morton

Speaker Bio

"We aren't just modeling data; we are virtualising human physiology with clinical-grade precision. At ELEM, we provide high-fidelity Virtual Human Hearts — enabling the bio-industry to simulate preclinical and clinical trials to predict outcomes much before the first patient is even enrolled."

I am an entrepreneur dedicated to accelerating the delivery of safe, effective medical treatments through In-Silico Clinical Trials and Precision Medicine. As founder and CEO of ELEM Biotech (a spin-off from the Barcelona Supercomputing Center), I develop and lead a multidisciplinary team bridging the gap between advanced physics-based AI and clinical reality: from science to market. By virtualising human organs—starting with the heart and lungs—we enable Biopharma and MedTech companies to de-risk R&D, reduce animal testing, and optimise trial design with unprecedented speed.